Stem Cells & Regenerative Medicine Congress USA 2015

INNOVATION.COLLABORATION. COMMERCIALIZATION.

  

 

Welcome to the Regenerative Renaissance

 

Since 1961, when the existence of Stem Cells was proven accidentally, regenerative medicine has bloomed, shrunk, contracted, been hated and misunderstood all at once. 

In 2008, the Stem Cells and Regenerative Medicine Congress had its inaugural year in the United States. Combined with President Obama’s promise to move the regenerative medicine industry forward, the event has grown year after year to become the premier event for those active in this space. 

At this year’s event the regenerative medicine industry is taking it to the next level and discussing how genomics is changing the field – and highlighting the commercialization and manufacturing stories that have helped spur the recent success. 

We've got content to suit your needs.

Stem Cells & Regenerative Medicine Congress USA

Cell Therapy at Stem Cells & Regenerative Medicine Congress USA

 

 

 

"Great event. You have a great team of hosts & organizers."

- 2014 Delegate

 

 

Today's unmet needs, tomorrow's treatments

Regenerative medicine is going through its renaissance today. Tomorrow will come the revolution.

Unmet needs abound in today’s healthcare. From orthopedics to diabetes, and with medicine getting increasingly personalized regenerative medicine stands at the perfect point. Regenerative medicine, by its definition, is personal, and no two individuals are alike, even if the treatment before it enters their body is the same. In 2015, we are exploring the future of regenerative medicine industry with our fantastic speaker line-up.

Inspirational speakers

Mike West at Stem Cells & Regenerative Medicine Congress USA

Michael D. West, Ph.D.

CEO

BioTime Inc.

Mary Laughlin at Stem Cells & Regenerative Medicine Congress USA

Mary Laughlin

Global Program Medical Director, Cell and Gene Therapy Unit

Novartis

Mahendra Rao at Stem Cells & Regenerative Medicine Congress USA

Mahendra Rao

VP for Regenerative Medicine

New York Stem Cell Foundation

Brock Reeve at Stem Cells & Regenerative Medicine Congress USA

Brock Reeve  

Executive Director

Harvard Stem Cell Institute  

UniQure at Stem Cells & Regenerative Medicine Congress USA

Hans Preusting

Chief Business Officer  

UniQure  

Meet the experts

 

Regenerative medicine isn’t just a story about science, it is a story about people. That story is just starting to get good. Personalized medicine? Regenerative medicine has been doing it for years. It’s about time the rest of the industry caught up.

 

  • Dr Rahul Aras at Stem Cells & Regenerative Medicine Congress USA
    Dr Rahul Aras
    Chief Executive Officer
    Juventas Therapeutics
    Dr Kurtis Bachman at Stem Cells & Regenerative Medicine Congress USA
    Dr Kurtis Bachman
    US Head, Computational and Systems Biology
    Janssen
  • Dr Gil Van Bokkelen at Stem Cells & Regenerative Medicine Congress USA
    Dr Gil Van Bokkelen
    Chairman and Chief Executive Officer
    Athersys, Inc.
    Dr Eric David at Stem Cells & Regenerative Medicine Congress USA
    Dr Eric David
    Chief Medical Officer
    Organovo
  • Luca Gattinoni at Stem Cells & Regenerative Medicine Congress USA
    Luca Gattinoni
    Investigator Experimental Transplantation and Immunology Branch
    National Institutes of Health
    Dr Robert Hariri at Stem Cells & Regenerative Medicine Congress USA
    Dr Robert Hariri
    Chairman, Founder and CSO
    Celgene Cellular Therapeutics
  • Dr Hans Klingemann at Stem Cells & Regenerative Medicine Congress USA
    Dr Hans Klingemann
    CMO & CSO
    NantKwest
    Antonio Lee at Stem Cells & Regenerative Medicine Congress USA
    Antonio Lee
    Chief Executive Officer & Managing Director
    MEDIPOST America, Inc.
  • Shelley Nelson at Stem Cells & Regenerative Medicine Congress USA
    Shelley Nelson
    regulatory professional
    Janssen R
    Daniel Orlando at Stem Cells & Regenerative Medicine Congress USA
    Daniel Orlando
    Chief Operating Officer
    Vericel Corporation
  • Mr Hans Preusting at Stem Cells & Regenerative Medicine Congress USA
    Mr Hans Preusting
    Business Development, Vice President
    Uniqure Bv
    Mr Brock Reeve at Stem Cells & Regenerative Medicine Congress USA
    Mr Brock Reeve
    Executive Director
    Harvard Stem Cell Institute
  • Mr Christopher Reinhard at Stem Cells & Regenerative Medicine Congress USA
    Mr Christopher Reinhard
    Chief Executive Officer
    Cardium Therapeutics Inc
    Cynthia Sherman at Stem Cells & Regenerative Medicine Congress USA
    Cynthia Sherman
    Senior Director, Health Policy
    Osiris Therapeutics, Inc
  • Dr Timothy Smith at Stem Cells & Regenerative Medicine Congress USA
    Dr Timothy Smith
    Chief Executive Officer
    Octane Biotech
    Mr Devyn Smith at Stem Cells & Regenerative Medicine Congress USA
    Mr Devyn Smith
    Head of Strategy, Pharmatherapeutics Research & Development
    Pfizer Global Research and Development
  • Dr Michael D West, Ph.D. at Stem Cells & Regenerative Medicine Congress USA
    Dr Michael D West, Ph.D.
    Chief Executive Officer and Director
    BioTime, Inc.

 

 

"A highly valuable event, an excellent venue, coverage of a wide variety of topics."

- 2014 Delegate

 

 

Our Sponsors


  • Gold Sponsor

    Octane Medical Group at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    WuXi AppTec, Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    CorMatrix at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    Beckman Coulter at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    American Fluoroseal Corp Part of Saint Gobain Performance Plastics at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    SynGen Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    TrakCel at Stem Cells & Regenerative Medicine Congress USA

SEE OUR SPONSORS